NYSE:CBT - Cabot Stock Price, Price Target & More Sign in or create an account to add this stock to your watchlist. Get Started $62.63 -0.27 (-0.43 %) (As of 07/16/2018 02:08 PM ET)Previous Close$63.24Today's Range$62.63 - $63.3752-Week Range$50.56 - $68.63Volume3,392 shsAverage Volume358,274 shsMarket Capitalization$3.89 billionP/E Ratio18.42Dividend Yield2.10%Beta1.35 Company ProfileFinancialsAnalyst RatingsDividend HistoryEarnings HistoryInsider TradesHeadlinesOptions ChainSEC FilingsSocial MediaChart Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Cabot Corporation operates as a specialty chemicals and performance materials company. The company offers carbon black, a form of elemental carbon used to enhance the physical properties of the systems and applications in which it is incorporated; and rubber blacks for use as a rubber reinforcing agent and performance additive in tires, hoses, belts, extruded profiles, and molded goods. It also provides compounds of carbon black and rubber primarily for tire applications; and cesium formate, a drilling and completion fluid for use in high pressure and high temperature oil and gas well construction. In addition, the company offers specialty grades of carbon black used in inks, coatings, plastics, adhesives, toners, batteries, and displays applications; masterbatch and conductive compound products for use in automotive, industrial, packaging, consumer products, and electronics industries; inkjet colorants used in the inkjet printing applications; and fumed silica, fumed alumina, and dispersions for automotive, construction, microelectronics, batteries, and consumer products industries, as well as aerogel, a hydrophobic, silica-based particle for use in various thermal insulation and specialty chemical applications. Further, it provides activated carbon products used for the purification of water, air, food and beverages, pharmaceuticals, and other liquids and gases; as a chemical carrier; and as a colorant or a decolorizing agent. The company sells its products primarily through distributors and sales representatives in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. Cabot Corporation was founded in 1882 and is headquartered in Boston, Massachusetts. Receive CBT News and Ratings via Email Sign-up to receive the latest news and ratings for CBT and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NYSE Industry Miscellaneous chemical products Sub-IndustryCommodity Chemicals SectorBasic Materials SymbolNYSE:CBT CUSIP12705510 Webwww.cabot-corp.com Phone617-345-0100 Debt Debt-to-Equity Ratio0.47 Current Ratio1.67 Quick Ratio1.07 Price-To-Earnings Trailing P/E Ratio18.42 Forward P/E Ratio15.28 P/E Growth1.48 Sales & Book Value Annual Sales$2.72 billion Price / Sales1.43 Cash Flow$5.9534 per share Price / Cash10.52 Book Value$25.73 per share Price / Book2.43 Profitability EPS (Most Recent Fiscal Year)$3.43 Net Income$241 million Net Margins-6.14% Return on Equity15.83% Return on Assets7.29% Miscellaneous Employees4,500 Outstanding Shares61,820,000Market Cap$3,888.48 Cabot (NYSE:CBT) Frequently Asked Questions What is Cabot's stock symbol? Cabot trades on the New York Stock Exchange (NYSE) under the ticker symbol "CBT." How often does Cabot pay dividends? What is the dividend yield for Cabot? Cabot declared a quarterly dividend on Monday, July 16th. Shareholders of record on Friday, August 31st will be given a dividend of $0.33 per share on Friday, September 14th. This represents a $1.32 annualized dividend and a yield of 2.11%. View Cabot's Dividend History. How were Cabot's earnings last quarter? Cabot Corp (NYSE:CBT) released its quarterly earnings data on Monday, May, 7th. The specialty chemicals company reported $1.04 earnings per share for the quarter, beating the consensus estimate of $1.00 by $0.04. The specialty chemicals company had revenue of $818 million for the quarter, compared to analysts' expectations of $746.30 million. Cabot had a positive return on equity of 15.83% and a negative net margin of 6.14%. Cabot's quarterly revenue was up 20.6% on a year-over-year basis. During the same period in the previous year, the firm earned $0.87 earnings per share. View Cabot's Earnings History. When is Cabot's next earnings date? Cabot is scheduled to release their next quarterly earnings announcement on Monday, August, 6th 2018. View Earnings Estimates for Cabot. What price target have analysts set for CBT? 7 brokers have issued 12 month target prices for Cabot's stock. Their forecasts range from $57.00 to $82.00. On average, they expect Cabot's share price to reach $72.8333 in the next twelve months. This suggests a possible upside of 16.3% from the stock's current price. View Analyst Ratings for Cabot. What is the consensus analysts' recommendation for Cabot? 7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cabot in the last year. There are currently 1 hold rating and 6 buy ratings for the stock, resulting in a consensus recommendation of "Buy." Are investors shorting Cabot? Cabot saw a increase in short interest in June. As of June 15th, there was short interest totalling 1,256,070 shares, an increase of 87.0% from the May 31st total of 671,818 shares. Based on an average daily volume of 571,185 shares, the days-to-cover ratio is presently 2.2 days. Currently, 2.1% of the shares of the company are short sold. View Cabot's Current Options Chain. Who are some of Cabot's key competitors? Some companies that are related to Cabot include Versum Materials (VSM), Platform Specialty Products (PAH), WD-40 (WDFC), Orion Engineered Carbons (OEC), Advanced Emissions Solutions (ADES), Flotek Industries (FTK), Pure Bioscience, Inc. Common Stock (PURE), GlyEco (GLYE), HighCom Global Security (HCGS) and Ener-Core (ENCR). Who are Cabot's key executives? Cabot's management team includes the folowing people: Mr. Sean D. Keohane, Pres, CEO & Director (Age 51)Mr. Brian A. Berube, Sr. VP & Gen. Counsel (Age 56)Mr. Nicholas S. Cross, Exec. VP, Pres of Performance Chemicals segment & Pres of EMEA region (Age 57)Mr. Hobart C. Kalkstein, Sr. VP, Pres of Reinforcement Materials Segment & Pres of Americas Region (Age 48)Mr. Patrick M. Prevost, Advisor & Director (Age 63) Has Cabot been receiving favorable news coverage? Headlines about CBT stock have been trending positive on Monday, according to Accern Sentiment Analysis. The research firm identifies negative and positive media coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Cabot earned a media sentiment score of 0.43 on Accern's scale. They also gave news headlines about the specialty chemicals company an impact score of 47.48 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock's share price in the next several days. Who are Cabot's major shareholders? Cabot's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Cabot Wellington LLC (0.56%), Peregrine Capital Management LLC (0.21%), Bank of Montreal Can (0.08%), CenturyLink Investment Management Co (0.03%), Xact Kapitalforvaltning AB (0.02%) and State of Alaska Department of Revenue (0.01%). Company insiders that own Cabot stock include Brian A Berube, Eduardo E Cordeiro, Gottberg Friedrich Von, Hobart Kalkstein, James Patrick Kelly, Michael M Morrow, Nicholas S Cross, Patrick M Prevost and Sean D Keohane. View Institutional Ownership Trends for Cabot. Which institutional investors are selling Cabot stock? CBT stock was sold by a variety of institutional investors in the last quarter, including Cabot Wellington LLC, CenturyLink Investment Management Co and Bank of Montreal Can. Company insiders that have sold Cabot company stock in the last year include Brian A Berube, Gottberg Friedrich Von, Hobart Kalkstein, James Patrick Kelly, Nicholas S Cross, Patrick M Prevost and Sean D Keohane. View Insider Buying and Selling for Cabot. Which institutional investors are buying Cabot stock? CBT stock was bought by a variety of institutional investors in the last quarter, including Xact Kapitalforvaltning AB, Peregrine Capital Management LLC and State of Alaska Department of Revenue. View Insider Buying and Selling for Cabot. How do I buy shares of Cabot? Shares of CBT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Cabot's stock price today? One share of CBT stock can currently be purchased for approximately $62.63. How big of a company is Cabot? Cabot has a market capitalization of $3.89 billion and generates $2.72 billion in revenue each year. The specialty chemicals company earns $241 million in net income (profit) each year or $3.43 on an earnings per share basis. Cabot employs 4,500 workers across the globe. How can I contact Cabot? Cabot's mailing address is TWO SEAPORT LANE SUITE 1300, BOSTON MA, 02210. The specialty chemicals company can be reached via phone at 617-345-0100 or via email at [email protected] MarketBeat Community Rating for Cabot (NYSE CBT)Community Ranking: 2.4 out of 5 ( )Outperform Votes: 272 (Vote Outperform)Underperform Votes: 298 (Vote Underperform)Total Votes: 570MarketBeat's community ratings are surveys of what our community members think about Cabot and other stocks. Vote "Outperform" if you believe CBT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CBT will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 7/16/2018 by MarketBeat.com StaffFeatured Article: Should I follow buy, hold and sell recommendations?